Preliminary proteomic analysis of A549 cells infected with avian influenza virus H7N9 and influenza a virus H1N1

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Ding, Xiaoman ^a   Lu, Jiahai ^a   Yu, Ruoxi ^b   Wang, Xin ^c   Wang, Ting ^c   Dong, Fangyuan ^c   Peng, Bo ^c   Wu, Weihua ^c   Liu, Hui ^c   Geng, Yijie ^c   Zhang, Renli ^c   Ma, Hanwu ^c   Cheng, Jinquan ^c   Yu, Muhua ^c   Fang, Shisong ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 5A; ORNITHINE OXOACID AMINOTRANSFERASE; PLATELET ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT BETA; POLY(RC) BINDING PROTEIN 1; PROTEIN CAPZA1; UNCLASSIFIED DRUG; VIRUS PROTEIN; PROTEOME;

A549 CELL LINE; ARTICLE; AVIAN INFLUENZA; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DOWN REGULATION; HUMAN; HUMAN CELL; INFLUENZA A; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H7N9); MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; VALIDATION PROCESS; VIRUS STRAIN; VIRUS VIRULENCE; WESTERN BLOTTING; A-549 CELL LINE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; INFLUENZA; METABOLISM;

A549 CELLS; CYTOPATHOGENIC EFFECT, VIRAL; GENE EXPRESSION REGULATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; PROTEOME;

EID: 84971327165     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156017     Document Type: Article

References (50)

1. Wu Y, Shen L, Ding Y, Tanaka Y, Zhang W. Preliminary success in the characterization and management of a sudden breakout of a novel H7N9 influenza A virus. Int J Biol Sci.2014; 10(1): 109-18. doi: 10.7150/ijbs.8198 PMID: 24520209.
2. Van Ranst M, Lemey P. Genesis of avian-origin H7N9 influenza A viruses. Lancet. 2013; 381(9881): 1883-5. doi: 10.1016/S0140-6736(13)60959-9 PMID: 23643449.
3. Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, et al. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nat Comms. 2013; 4: 2854. doi: 10.1038/nco mms3854 PMID: 24326875.
4. Yu H, Cowling BJ, Feng L, Lau EH, Liao Q, Tsang TK, et al. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet.2013; 382(9887): 138-45. doi: 10.1016/S0140-6736(13)61207-6 PMID: 23803487.
5. To KK, Chan JF, Chen H, Li L, Yuen KY.The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect Dis.2013; 13(9): 809-21. doi: 10.1016/ S1473-3099(13)70167-1 PMID: 23969217.
6. Zeng H, Belser JA, Goldsmith CS, Gustin KM, Veguilla V, Katz JM, et al. A(H7N9) virus results in early induction of proinflammatory cytokine responses in both human lung epithelial and endothelial cells and shows increased human adaptation compared with avian H5N1 virus. J Virol.2015; 89(8): 4655-67. doi: 10.1128/JVI.03095-14 PMID: 25673714.
7. Li Q, Zhou L, Zhou M, Chen Z, Li F, Wu H, et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med.2014; 370(6): 520-32. doi: 10.1056/NEJMoa1304617 PMID: 23614499.
8. Sakai K, Ami Y, Tahara M, Kubota T, Anraku M, Abe M, et al. The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses. J Virol.2014; 88(10): 5608-16. doi: 10.1128/JVI.03677-13 PMID: 24600012.
9. Morrison J, Josset L, Tchitchek N, Chang J, Belser JA, Swayne DE, et al. H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in mice. J Virol.2014; 88(18): 10556-68. doi: 10.1128/ JVI.00570-14 PMID: 24991006.
10. Arunachalam R. Adaptive evolution of a novel avian-origin influenza A/H7N9 virus. Genomics.2014; 104(6 Pt B): 545-53. doi: 10.1016/j.ygeno.2014 PMID: 25449177.
11. Zhou J, Wang D, Gao R, Zhao B, Song J, Qi X, et al. Biological features of novel avian influenza A (H7N9) virus. Nature.2013; 499(7459): 500-3. doi: 10.1038/ nature12379 PMID: 23823727.
12. Fang S, Zhang K, Wang T, Wang X, Lu X, Peng B, et al. Primary study on the lesions and specific proteins in BEAS-2B cells induced with the 2009 A (H1N1) influenza virus. Appl Microbiol Biot.2014; 98 (23): 9691-701. doi: 10.1007/s002 53-014-5852-y PMID: 24903817.
13. Vester D, Rapp E, Gade D, Genzel Y, Reichl U. Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines. Proteomics.2009; 9(12): 3316-27. doi: 10. 1002/pmic.200800893 PMID: 19504497.
14. Cheung CY, Chan EY, Krasnoselsky A, Purdy D, Navare AT, Bryan JT, et al. H5N1 virus causes significant perturbations in host proteome very early in influenza virus-infected primary human monocytederived macrophages. J Infect Dis,2012; 206(5): 640-5. doi: 10.1093/infdis/jis423 PMID: 22822004.
15. Simon PF, McCorrister S, Hu P, Chong P, Silaghi A, Westmacott G, et al. Highly pathogenic H5N1 and novel H7N9 influenza A viruses induce more profound proteomic host responses than seasonal and pandemic H1N1 strains. J Proteome Res.2015; 14(11):4511-23. doi: 10.1021/acs.jproteome.5b00196 PMID: 26381135.
16. Wodal W, Schwendinger MG, Savidis-Dacho H, Crowe BA, Hohenadl C, Fritz R, et al. Immunogenicity and protective efficacy of a vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs. PLoS One.2015; 10(2): e113963. doi: 10.1371/journal.pone.0113963 PMID: 25719901.
17. Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature.2013; 501 (7468):551-5. doi: 10.1038/nature12392 PMID: 23842494.
18. Yamayoshi S, Fukuyama S, Yamada S, Zhao D, Murakami S, Uraki R, et al. Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hosts. Sci Rep.2015; 5: 8039. doi: 10.10 38/srep08039 PMID: 25623817.
19. Tjoelker LW, Wilder C, Eberhardt C, Stafforini DM, Dietsch G, Schimpf B, et al. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature.1995; 374(6522):549-53. PMID: 7700381.
20. Shafaghat F, Abbasi-Kenarsari H, Majidi J, Movassaghpour AA, Shanehbandi D, Kazemi T. Preparation of proper immunogen by cloning and stable expression of cDNA coding for human hematopoietic stem cell marker CD34 in NIH-3T3 mouse fibroblast cell line. Adv Pharm Bull.2015; 5(1):69-75. doi: 10.5681/ap b.2015.009 PMID: 25789221.
21. Hopmann R, Cooper JA, Miller KG. Actin organization, bristle morphology, and viability are affected by actin capping protein mutations in Drosophila. J Cell Biol.1996; 133(6): 1293-305. PMID: 8682865.
22. Lee SK, Kim Y, Kim S, Lee JH, Cho K, Lee SS, et al. Differential expression of cell surface proteins in human bone marrow mesenchymal stem cells cultured with or without basic fibroblast growth factor containing medium. Proteomics.2009; 9(18): 4389-405. doi: 10.1002/pmic.200900165 PMID: 19655310.
23. Matsuo K, Xiang Y, Nakamura H, Masuko K, Yudoh K, Noyori K, et al. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res Ther.2006; 8(6): R175. PMID: 17125526.
24. Hug C, Jay PY, Reddy I, McNally JG, Bridgman PC, Elson EL, et al. Capping protein levels influence actin assembly and cell motility in dictyostelium. Cell.1995; 81(4): 591-600. PMID: 7758113.
25. Delalle I, Pfleger CM, Buff E, Lueras P, Hariharan IK. Mutations in the Drosophila orthologs of the F-actin capping protein alpha-and beta-subunits cause actin accumulation and subsequent retinal degeneration. Genetics.2005; 171(4): 1757-65. PMID: 16143599.
26. Doimo M, Desbats MA, Baldoin MC, Lenzini E, Basso G, Murphy E, et al. Functional analysis of missense mutations of OAT, causing gyrate atrophy of choroid and retina. Hum Mutat.2013; 34(1): 229-36. doi: 10.1002/humu.22233 PMID: 23076989.
27. Juncosa JI, Lee H, Silverman RB. Two continuous coupled assays for ornithine-δ-aminotransferase. Anal Biochem.2013; 440(2):145-9. doi: 10.1016/j.ab.2013.05.0 25 PMID: 23747282.
28. Hampel A, Huber C, Geffers R, Spona-Friedl M, Eisenreich W, Bange FC. Mycobacterium tuberculosis is a natural ornithine aminotransferase (rocD) mutant and depends on Rv2323c for growth on arginine. PLoS One.2015; 10(9): e136914. doi: 10.1371/journal.pone.0136914 PMID: 26368558.
29. Da Rocha IMA, Vitorello VA, Silva JS, Ferreira-Silva SL, Viégas RA, Silva EN, et al. Exogenous ornithine is an effective precursor and the δ-ornithine amino transferase pathway contributes to proline accumulation under high N recycling in salt-stressed cashew leaves. J Plant Physiol.2012; 169(1): 41-9. doi: 10.1016/j.jp lph.2011.08.001 PMID: 21903295.
30. Funck D, Stadelhofer B, Koch W. Ornithine-δ-aminotransferase is essential for arginine catabolism but not for proline biosynthesis. BMC Plant Biol.2008; 8: 40. doi: 10.1186/1471-2229-8-40 PMID: 18419821.
31. Wagemaker MJ, Eastwood DC, Welagen J, van der Drift C, Jetten MS, Burton K, et al. The role of ornithine aminotransferase in fruiting body formation of the mushroom Agaricus bisporus. Mycol Res.2007; 111(Pt 8):909-18. PMID: 17703933.
32. Wang G, Shang L, Burgett AW, Harran PG, Wang X. Diazonamide toxins reveal an unexpected function for ornithine delta-amino transferase in mitotic cell division. Proc Natl Acad Sci U S A.2007; 104(7): 2068-73. PMID: 17287350.
33. Wagener R, Aukema SM, Schlesner M, Haake A, Burkhardt B, Claviez A, et al. The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma. Genes Chromosomes Cancer.2015; 54(9): 555-64. doi: 10.10 02/gcc.22268 PMID: 26173642.
34. Huo LR, Liang JT, Zou JH, Wang LY, Li Q, Wang XM. Possible novel roles of poly(rC)-binding protein 1 in SH-SY5Y neurocytes: an analysis using a dynamic Bayesian network. Neurosci Bull.2012; 28(3): 282-90. doi: 10.1007/s12264-012-1242-6 PMID: 22622828.
35. Huo LR, Ju W, Yan M, Zou JH, Yan W, He B, et al. Identification of differentially expressed transcripts and translatants targeted by knock-down of endogenous PCBP1. Biochim Biophys Acta.2010; 1804 (10): 1954-64. doi: 10.10 16/j.bbapap.2010.07.002 PMID: 20624489.
36. Shi Z, Zhang T, Long W, Wang X, Zhang X, Ling X, et al. Down-regulation of Poly(rC)-binding protein 1 correlates with the malignant transformation of hydatidiform moles. Int J Gynecol Cancer.2012; 22(7): 1125-9. doi: 10.1097/IG C.0b013e3182606ac3 PMID: 22801034.
37. Huo LR, Zhong N. Identification of transcripts and translatants targeted by overexpressed PCBP1. Biochim Biophys Acta.2008; 1784(11): 1524-33. doi: 10.1016/j.bbapap.2008.06.017 PMID: 18656558.
38. Lee SB, Park JH, Kaevel J, Sramkova M, Weigert R, Park MH. The effect of hypusine modification on the intracellular localization of eIF5A. Biochem Biophys Res Commun.2009; 383(4): 497-502. doi: 10. 1016/j.bbrc.2009.04.049 PMID: 19379712.
39. Lu Z, Song Q, Yang J, Zhao X, Zhang X, Yang P, et al. Comparative proteomic analysis of anti-cancer mechanism by periplocin treatment in lung cancer cells. Cell Physiol Biochem.2014; 33(3): 859-68. doi: 10.1159/000358658 PMID: 24685647.
40. Bevec D, Jaksche H, Oft M, Wohl T, Himmelspach M, Pacher A, et al. Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science.1996; 271(5257):1858-60. PMID: 8596953.
41. Cracchiolo BM, Heller DS, Clement PMJ, Wolff EC, Park M, Hanauske-Abel HM. Eukaryotic initiation factor 5A-1 (eIF5A-1) as a diagnostic marker for aberrant proliferation in intraepithelial neoplasia of the vulva.Gynecol Oncol.2004; 94(1): 217-22. PMID: 15262146.
42. Maier B, Ogihara T, Trace AP, Tersey SA, Robbins RD, Chakrabarti SK, et al. The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice. J Clin Invest.2010; 120(6): 2156-70. doi: 10.1172/JCI3 8924 PMID: 20501948.
43. Zanelli CF, Valentini SR. Is there a role for eIF5A in translation? Amino Acids.2007; 33(2): 351-8. PMID: 17578650.
44. Hwang H, Moon P, Lee J, Kim J, Lee W, Ryu SH, et al. Identification of the target proteins of rosiglitazone in 3T3-L1 adipocytes through proteomic analysis of cytosolic and secreted proteins. Mol Cells.2011; 31(3): 239-46. doi: 10.1007/s 10059-011-0026-6 PMID: 21347706.
45. Tjoelker LW, Stafforini DM. Platelet-activating factor acetylhydrolases in health and disease. Biochim Biophys Acta.2000; 1488(1-2):102-23. PMID: 11080681.
46. Manya H, Aoki J, Watanabe M, Adachi T, Asou H, Inoue Y, et al. Switching of platelet-activating factor acetylhydrolase catalytic subunits in developing rat brain. J Biol Chem.1998; 273(29): 18567-72. PMID: 9660828.
47. Riera J, Rodríguez R, Carcedo MT, Campa VM, Ramos S, Lazo PS. Isolation and characterization of nudC from mouse macrophages, a gene implicated in the inflammatory response through the regulation of PAF-AH(I) activity. FEBS Lett.2007; 581(16): 3057-62. PMID: 17555748.
48. Manya H, Aoki J, Kato H, Ishii J, Hino S, Arai H, et al. Biochemical characterization of various catalytic complexes of the brain platelet-activating factor acetylhydrolase. J Biol Chem.1999; 274(45): 31827-32. PMID: 10542206.
49. Livnat I, Finkelshtein D, Ghosh I, Arai H, Reiner O. PAF-AH catalytic subunits modulate the Wnt pathway in developing GABAergic neurons. Front Cell Neurosci.2010; 4 pii: 19. doi: 10.3389/fncel.2010.00019 PMID: 20725507.
50. Snyder F. Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim Biophys Acta.1995; 1254(3): 231-49. PMID: 7857964.